| |
| |
|
| Insider
Information: |
Parshall B Lynne |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,619,493 |
|
|
Indirect Shares
|
7,049,500 |
|
|
| Direct
Value |
$16,734,476 |
|
|
|
Indirect Value
|
$16,143,355 |
|
|
| Total
Shares |
12,668,993 |
|
|
| Total
Value |
$32,877,831 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -84.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Director |
2023-12-28 |
82,588 |
2016-12-15 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2014-11-03 |
5,516,305 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
Director |
2024-05-15 |
20,600 |
2020-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• • – |
2014-01-30 |
4 |
AS |
$50.36 |
$1,989,882 |
D/D |
(39,510) |
4,022 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-06-25 |
4 |
AS |
$7.84 |
$21,566 |
D/D |
(2,750) |
7,046,750 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-06-26 |
4 |
AS |
$7.89 |
$13,408 |
D/D |
(1,700) |
7,045,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-06-27 |
4 |
AS |
$7.91 |
$24,931 |
D/D |
(3,150) |
7,041,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-02 |
4 |
AS |
$8.07 |
$25,011 |
D/D |
(3,100) |
7,038,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-03 |
4 |
AS |
$8.07 |
$9,678 |
D/D |
(1,200) |
7,037,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-09 |
4 |
AS |
$7.08 |
$12,748 |
D/D |
(1,800) |
7,035,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-10 |
4 |
AS |
$6.69 |
$30,109 |
D/D |
(4,500) |
7,031,300 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-11 |
4 |
AS |
$6.48 |
$11,339 |
D/D |
(1,750) |
7,029,550 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-16 |
4 |
AS |
$6.59 |
$23,058 |
D/D |
(3,500) |
7,026,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-17 |
4 |
AS |
$6.58 |
$32,906 |
D/D |
(5,000) |
7,021,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-18 |
4 |
AS |
$6.80 |
$34,001 |
D/D |
(5,000) |
7,016,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-23 |
4 |
AS |
$6.88 |
$11,702 |
D/D |
(1,700) |
7,014,350 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-24 |
4 |
AS |
$6.81 |
$12,598 |
D/D |
(1,850) |
7,012,500 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-25 |
4 |
AS |
$6.55 |
$11,137 |
D/D |
(1,700) |
7,010,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-30 |
4 |
AS |
$6.60 |
$6,602 |
D/D |
(1,000) |
7,009,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-07-31 |
4 |
AS |
$6.42 |
$11,235 |
D/D |
(1,750) |
7,008,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-01 |
4 |
AS |
$6.21 |
$16,153 |
D/D |
(2,600) |
7,005,450 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-06 |
4 |
AS |
$7.08 |
$22,300 |
D/D |
(3,150) |
7,002,300 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-07 |
4 |
AS |
$6.66 |
$17,322 |
D/D |
(2,600) |
6,999,700 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-08 |
4 |
AS |
$6.80 |
$12,583 |
D/D |
(1,850) |
6,997,850 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-13 |
4 |
AS |
$7.02 |
$15,788 |
D/D |
(2,250) |
6,995,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-14 |
4 |
AS |
$7.04 |
$12,324 |
D/D |
(1,750) |
6,993,850 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-15 |
4 |
AS |
$6.98 |
$10,115 |
D/D |
(1,450) |
6,992,400 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-08-20 |
4 |
AS |
$7.14 |
$21,424 |
D/D |
(3,000) |
6,989,400 |
0 |
- |
|
304 Records found
|
|
Page 5 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
